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ABSTRACT 
 
The objective of the study was to investigate the hypoglycaemic properties of Malaysian cocoa 
(Theobroma cacao) polyphenols extract in-vivo and in-vitro. Cocoa extract (CE) (containing 190 
- 286 mg total polyphenol per gram extract) was prepared from fermented and roasted (140 °C, 
20 min) beans by extracting with 80% ethanol in the ratio of 1 to 10. For the in-vivo study, the 
CE was given in three dosages (1%, 2%, and 3%) to groups of normal and diabetic rats for a 
period of 4 weeks by force-feeding. Results showed that dosages of 1% and 3% CE significantly 
reduced (p < 0.05) the plasma glucose levels in the diabetic rats. BRIN-BD11 cell lines were 
used to evaluate the effect of CE on insulin secretions. An in-vitro study demonstrated that CE at 
a concentration of 0.1 mg/ml significantly increased (p < 0.05) insulin secretion compared to the 
control. The results of this study showed that Malaysian cocoa polyphenol extract have the 
potential of being a hypoglycaemic agent. Further studies are needed to elucidate the mechanism 
action of polyphenols present in CE, which could be utilised to lower the plasma glucose levels 
and stimulate insulin secretion in patients with Diabetes Mellitus Type 2.  
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INTRODUCTION 
 
 
Diabetes mellitus is a non-communicable disease, which is considered one of the five 
leading causes of death in the world today. Recently, the search for appropriate hypoglycaemic 
agents has focused on plants used in traditional medicine, partly because of leads provided by 
traditional medicine to natural products that it may be better treatments than currently used 
drugs
1, 2, 3
. Drug such as sulphonylureas, lead to higher risk of hypoglycaemia, and metformin 
brings a higher risk of lactic acidosis
4
.  Due to side effects of these drugs, many studies have 
been conducted to explore natural products derived from plants which have potential 
hypoglycaemic effect
5,6,7,8
.  
Besides the traditional medicinal plants, cocoa beans were thought to have fearsome 
magical powers by the Mayas and were carefully used in rituals, religious ceremonies and 
healings by priests. The Mayas used cocoa medicinally as a treatment for fever, coughs and to 
help dispel even discomfort during pregnancy. After the 16
th
 century conquest of Central 
America by Spain, Cortes introduced cocoa to Europe, where it was typically viewed as a 
healthy and nutritious beverage
9
. Cocoa beans were recently recognised as a rich source of 
polyphenols, specifically procyanidins. Zumbe
10
 reported that total polyphenol content of the 
cocoa bean is about 6-8% by weight of the dry bean. Some of the earliest studies on procyanidins 
also established that the major flavanoids of cocoa bean are catechin, epicatechin, and the dimers 
epicatechin-(4β→8)-catechin (procyanidin B-l) and epicatechin-(4β→8)-epicatechin 
(procyanidin B-2) and the trimer [epicatechin-(4β→8)2 epicatechin (procyanidin C-l)11,12. On 
fermentation and roasting, these procyanidins are converted to the largely insoluble red-brown 
material (tanning) resulting in the characteristic colour and taste of chocolate
13
.  
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Polyphenols have been researched for decades, mostly because of their antioxidant 
properties
14,15,16
. The consumption of flavonoids, including those found in cocoa and other cocoa 
products have been associated with reduction in the risk of heart diseases, having potentially 
beneficial effects on inflammatory activity, and being cancer-protective agents
17
. Recent research 
showed the ability of cocoa to reduce platelet activation in vivo, which can cause 
atherosclerosis
18
. Oxidative stress is well known to be an important factor leading to chronic 
disease such as diabetes mellitus and atherosclerosis. Sabu et al.
19
 reported that administration of 
green tea polyphenols was found to reduce oxidative stress and serum glucose tolerance in 
alloxan-diabetic rats. A similar finding was found by Ceriello et al.
20
 for red wine in humans. 
Our study on oral glucose tolerance test (OGTT) of diabetic rats showed that cocoa extract could 
reduce the blood glucose levels
21
. However, limited studies have been done on the 
hypoglycaemic effect of polyphenol-rich cocoa extract. Therefore, this study was designed to 
assess the effectiveness of polyphenol-rich cocoa extract in reducing hyperglycaemia based on 
in-vivo (animal) and in-vitro studies. 
 
 
MATERIALS AND METHODS 
  
Preparation of Extract from Cocoa Beans 
Fermented and dried Malaysian cocoa beans were purchased from KL-Kepong Cocoa 
Products Sdn. Bhd., Port Klang, Selangor, Malaysia. The beans were roasted using an air-oven 
for 20 min at 140ºC
22
. After cooling to room temperature, the beans were deshelled using a 
cocoa breaker (Limprimita, John Gordon & Co., UK). The broken nibs were ground, then 
defatted with petroleum-ether (b.p 40-60ºC) using a Soxhlet apparatus in order to remove cocoa 
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butter. The defatted sample was air-dried to remove solvent residue. Extract was prepared by 
extracting the defatted powder with 80% (v/v) ethanol for 2 hr. The ethanol residue was removed 
from the extract using a rotary evaporator (Buchi Rotavor R-200, Switzerland) under reduced 
pressure for 20 min at 70ºC and the sample was then lyophilised. 
 
Determination of Total Phenolic Content 
The total phenolic content was determined according to the Folin-Ciocalteu method
23
. 
Briefly, the cocoa extract was dissolved in 80% (v/v) ethanol and then centrifuged (Rotofix 32, 
Hettich Zentrifugen, Germany) at 1000 x g for 15 min. A total of 100 µl of the supernatant was 
mixed with 0.75 ml of Folin-Ciocalteu reagent (previously diluted 10-fold with distilled water) 
and allowed to stand at room temperature for 5 min. Then, 0.75 ml of sodium carbonate (60g/L) 
solution was added to the mixture. After 90 min standing at room temperature, absorbance was 
read at 725 nm using a UV-Vis spectrophotometer (Anthelie Advanced 5, Secomam, France). A 
standard calibration curve was obtained from 0.02 - 0.12 mg/ml of (-)-epicatechin (Sigma Co., 
St. Louis, USA). Results were expressed as epicatechin equivalents in milligrams per gram 
extract.  
 
Animal study 
Ninety male (n = 90) Sprague-Dawley rats (150-200 g initial weights) were purchased 
from Syarikat Usaha Cahaya Sdn. Bhd., Batu Caves, Selangor, Malaysia. This study has been 
approved by the Animal Care and Use Committee of the Faculty of Medicine and Health 
Sciences, Universiti Putra Malaysia. The rats were housed in individual plastic cages with 
stainless steel covers and kept at room temperature (24-28°C) under 12 h dark-light cycle. Rats 
were allowed free access to their respective diets and water. All rats were allowed 1 week to 
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adapt to the environment before being given the treatment. The experiment was carried out over 
4 weeks, and body weights, food intakes, and blood glucose levels were recorded weekly.  The 
rats were divided into nine groups each consisting of ten rats as follows:  
Group 1: Normal rats administered saline solution 
Group 2: Normal rats administered 1% CE 
Group 3: Normal rats administered 2% CE 
Group 4: Normal rats administered 3% CE 
Group 5: Diabetic rats administered saline solution 
Group 6: Diabetic rats administered 1% CE 
Group 7: Diabetic rats administered 2% CE 
Group 8: Diabetic rats administered 3% CE 
Group 9: Diabetic rats administered glybenclamide (100 mg/ml in saline solution) 
 
CE was suspended in 0.9% (w/v) saline solution, then given daily (1 ml/ 100 g body weight) to 
the experimental rats by gastric intubation, using a force feeding needle. The rats were treated 
with their respective treatments after induction of diabetic conditions with streptozotocin (STZ).  
 
Induction of Diabetes 
The substance used for inducing hyperglycemia in the rats is STZ (Sigma Co., St. Louis, 
USA). After an overnight fast, rats were injected intravenously with 45 mg/kg body weight of 
STZ dissolved in 0.05 M citrate buffer, pH 4.5. Normal rats were injected with the same volume 
of 0.05 M citrate buffer. Three days after STZ injection, blood was collected from the tail vein 
for checking blood glucose levels using a Blood Glucose Sensor (MediSense Optium, Abbot 
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Laboratories, USA) to ensure that the rats had diabetes. Only rats with fasting blood glucose of 
15 mmol/l and above were included in this study. 
 
Determination of Plasma Glucose Levels 
At 0 and 4 weeks of experiment, 5 ml blood was collected from all rats through 
intracardiac and placed into a vacutainer tube. Then, the samples were centrifuged (Universal 
32®, Hettich Zentrifugen, Germany) for 10 min at 1000 x g at room temperature. The 
supernatant was collected and kept at -20°C for determination of plasma glucose levels using a 
Chemistry Analyzer (Hitachi 902 Automatic Analyzer, Japan).     
 
Measurement of insulin secretion 
For measurement of insulin-release from cell
 
monolayers, BRIN-BD11 cells were seeded 
into 24-multiwell plates (Nunc,
 
Roskilde, Denmark) at a density of 2.5 x 10
5
 cells per well in 
RPMI-1640 medium and allowed
 
to attach during overnight incubation (37 ºC; 5% CO2). After 
washing with PBS buffer, pre-incubations were performed using the
 
Krebs-Ringer bicarbonate 
buffer pH 7.4 for 40 min (37 ºC; 5% CO2). Then, the cells were incubated at 37 ºC under 5% 
CO2 with KRB buffer (pH 7.4) supplemented with different concentrations of CE. Following 30 
min of incubation, the aliquots were removed from each well, then centrifuged at 1000 x g for 1 
min at room temperature (Centrifuge 5414, Eppendorf, Germany), and supernatants were kept at 
-20 ºC before insulin radioimmunoassay. 
 
Statistical analysis  
Data were expressed as means ± S.E.M. One-way ANOVA was applied to find the 
difference between the groups. A Duncan’s multiple range test was used to find the significant 
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difference among the means. Results are considered significantly different at the level of p < 
0.05. 
 
RESULTS 
 
Table 1 showed the effect of CE on body weights in normal and diabetic rats. Body 
weights of all normal rats were significantly increased (p < 0.05) at the end of the experiment 
(week 4). No significant difference in body-weight changes were observed among the groups of 
normal rats. On the other hand, there were significant decreases (p < 0.05) in body weights of 
DC, DCE1, DCE2 and DG groups in diabetic rats. The weight loss in DC, DCE1, DCE2 and DG 
groups at the end of the experiment were 31%, 17%, 24% and 20% compared to week 0, 
respectively. The lost in body weights were not significantly different in DCE3 group compared 
to their initial weights. In addition, the mean body weight in DCE3 group was significantly 
higher (p < 0.05) compared to that of DC, DCE2 and DG groups. 
The initial plasma glucose levels of rats were in the range of 3.1 - 8.2 mmol/l. In normal 
rats, no significant difference in glucose levels were observed between week 0 and 4 (Fig. 1). For 
diabetic rats, plasma glucose levels had decreased significantly (p < 0.05) by feeding with 1% 
and 3 % CE (DCE1 and DCE3) at the end of experiment (Fig. 2). The reduction in percentages 
of plasma glucose levels in DCE1 and DCE3 groups were about 47% and 57%, respectively at 
the end of experiment. Plasma glucose levels in DCE2 and DG groups tend to be lower 
compared to DC, but it was not significantly different. 
 Figure 3 showed insulin secretion of BRIN-BD11 rat pancreatic cell-lines at various 
concentrations of CE. In this study, five concentrations (2.0, 1.0, 0.5, 0.1 and 0.05 mg/ml) of CE 
were used. CE at concentration of 0.1 mg/ml showed a significant increase (p < 0.05) in insulin 
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secretion compared to the control. BRIN-BD11 cells treated with 2.0 mg/ml CE was 
significantly lower (p < 0.05) compared to the control in insulin secretion. 
Results showed that CE, in the concentration range from 0.05–0.1 mg/ml, is capable of 
enhancing basal insulin secretion (at 2 mmol/l glucose) about 9-15% compared to the untreated 
BRIN-BD11 cell lines (control). In addition, CE at 0.05 mg/ml showed a slight increase in 
insulin secretion. However, insulin secretion at concentrations of 0.5, 1.0 and 2.0 mg/ml was 
lower compared to the control.  
 
DISCUSSION 
 
Very limited published data were available on hypoglycaemic effect of cocoa products 
based on in-vitro or in-vivo studies. This study was initiated to investigate the effect of CE on 
glucose levels using in-vitro (cell culture) and in-vivo (animal models) methods. For diabetic 
models, STZ was used to induce diabetic conditions in rats. Elsner et al.
24
 suggested that STZ 
induces hyperglycaemia through damaging DNA in the nuclei of pancreatic β-cells by alkylation, 
leading to an increase in poly (ADP-ribose) synthase. The increase in this enzyme activity results 
in a drastic decrease in nicotinamide adenine dinucleotide (NAD) concentrations of the β-cells, 
then a decrease in the number of β-cells and death of the cells. All these changes may induce 
dysfunction of the pancreas in insulin secretion. According to Thulesen et al.
25
, STZ transported 
into β-cells through glucose transporter GLUT-2 located on their cell membranes, and this will 
injure the mitochondria. This will inevitably lead to a reduction of ATP generation through 
electron transport system and an increase in ADP concentrations. Subsequent degradation of 
ADP provides hypoxanthine, a substrate of xanthine oxidase (XOD). When XOD reaction takes 
 10
place in β-cells, oxygen radicals which are free radicals will be produced, resulting in cell 
damage and the onset of the diabetic conditions. 
In this study, rats were administered orally (force-feeding) with their respective treatment 
daily. Results revealed that all normal rats showed an increase in body weights. It could be 
suggested that CE did not affect the growth of normal rats. In diabetic rats, a general decrease in 
body weights were observed after the injection of STZ. In the DCE3 group, however, no 
significant decrease was observed, suggesting that CE could normalize the weight loss caused by 
STZ. Although food and water intakes were not measured in this study, CE seemed to suppress 
polyphagia and polydypsia in the diabetic rats. This study clearly demonstrated that oral 
administration of CE at 1% and 3% exhibited a significant decrease (p < 0.05) in plasma glucose 
levels in STZ-induced diabetic rats compared to the control groups. 
Hypoglycaemic effects of some plants have been reported due to polyphenols
8,26
. Since 
cocoa beans is well known rich in polyphenols, it is possible that the hypoglycaemic effect could 
be related to these components. Polyphenols are reported to be the potential bioactive component 
for hypoglycaemic properties
27,28
. These components were reported to demonstrate marked 
antioxidant activity
11
. A significant reduction of plasma glucose levels in the group treated with 
CE may be due to the antioxidant properties of the CE. Antioxidant compounds are well known 
to possess free radical scavenging activity. Thus, it is suggested that glucose-lowering activity by 
CE could due to polyphenols that inhibit or suppress the generation of free radical by STZ in 
diabetic rats. In addition, flavanoids also have been reported to regenerate damaged β-cells in the 
alloxan diabetic rats
29
. Therefore, it is postulated that CE could also regenerate or rejuvenate the 
damaged of β-cells cause by STZ. 
Based on the previous studies of hypoglycaemic effect of plants and herbs, several 
mechanisms of lowering blood glucose were proposed. One of the proposed mechanisms of this 
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blood glucose lowering activity may be due to stimulation of peripheral glucose utilisation, 
especially in muscle and adipose tissue. Several medicinal plants have been reported to restore 
activity of key enzymes of glucose and glycogen metabolism which are strongly disturbed in 
STZ diabetic rats
30
. Several studies on plants and herbs compounds also revealed that these 
compounds have the properties of mimicking the insulin action, preferably by interacting with 
the glycoprotein residues of the insulin receptor and enhanced glucose uptake by cells
31
, which is 
called insulin-like activity.  
Insulin is essential for maintaining glucose homeostasis and regulating carbohydrate, 
lipid, and protein metabolism
32
. After a meal, blood glucose levels increase and insulin plays a 
major role in keeping blood glucose levels within a narrow range. The β-cells of the pancreas 
respond to increasing glucose levels by releasing insulin into the blood. Insulin affects glucose 
turnover in many tissues. In liver, insulin inhibits glycogenolysis and gluconeogenesis
33
. In 
skeletal muscle, that accounts for approximately 75 % of insulin-mediated glucose disposal after 
a glucose challenge
34,35
, insulin promotes glucose uptake into cells. 
It is strongly suggested that CE exhibited significant antihyperglycaemic activities in 
STZ-induced rats. However, the mechanism of the hypoglycaemic effect of the CE is not clear. 
Although pancreatic regeneration after partial resection or pancreatic injury has been 
demonstrated in animal models, whether regeneration occurs or not in human pancreas is still 
controversial. Studies by Tsiotos et al.
36
 revealed that human pancreas does not regenerate after 
partial anatomical resection. Yanardag et al.
37
 reported that plant therapy cannot regenerate β-
cells of the endocrine pancreas. Several published reports showed that antihyperglycaemic plants 
may affect the circulating insulin level
38,39
. This study suggests that the mechanism on 
hypoglycaemic effect of CE could also be due to the surviving β-cells which are still able to 
release more insulin. 
 12
Studies showed that certain plants (Agrimony eupatoria and Eucalyptus globules) could 
improved insulin secretion using BRIN-BD11 cell lines
40,41
. Based on the possibility that CE 
might stimulate the release of insulin from β-cells, BRIN-BD11 cell lines were used to evaluate 
the CE effect on insulin secretion. Incubations were performed with glucose-responsive BRIN-
BD11
 
cells
42
 to investigate the possible effects
 
of CE on insulin secretion in vitro. The results 
showed that CE at 0.1 mg/ml was able to stimulate the insulin secretion in BRIN-BD11 cell 
lines. The study indicated that the CE have the potential of reducing high blood glucose levels 
through enhancing insulin secretion in partially damaged pancrease. 
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TABLE 1. EFFECT OF COCOA EXTRACT (CE) ON BODY WEIGHT OF RATS 
 
 
Group                                       n                             Body weight (g) 
 
                                                               week 0                          week 4 
 
Normal control (NC)                8      184.4 ± 5.7
a
               279.8 ± 8.0
cd
             
 
Normal + 1% CE (NCE1)         8      182.2 ± 6.2
a
               282.6 ± 7.3
d                          
 
  
Normal + 2% CE (NCE2)         9      184.1 ± 7.3
a
               277.9 ± 12.0
cd                       
 
 
Normal + 3% CE (NCE3)        10      180.4 ± 7.5
a
               265.1 ± 12.0
cd
                      
 
Diabetes control (DC)               6      256.4 ± 12.1
cd
            176.4 ± 18.3
a                                   
 
 
Diabetes + 1% CE (DCE1)       4      254.5 ± 10.6
cd
            212.5 ± 2.5
ab                           
 
 
Diabetes + 2%CE (DCE2)        5      249.0 ± 12.1
bcd
           189.0 ± 23.7
a                   
 
 
Diabetes + 3% CE (DCE3)       5      254.7 ± 10.8
cd 
           241.8 ± 26.1
bc                     
 
 
Diabetes + Glibenclamide (DG)  4      248.6 ± 10.2
bcd
           197.8 ± 7.1
a                       
 
 
Values were expressed as means ± S.E.M. Different letters indicated significant difference 
at the level of p < 0.05. Body weights were measured at about 0900 hr every week. 
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Values with different superscripts were statistically significant at the level of p < 0.05. 
NC: Normal control (n = 8); NCE1: Normal + 1% CE (n = 8); NCE2: Normal + 2% CE 
(n = 9); NCE3: Normal + 3% CE (n = 10). 
 
 
 
 
FIG. 1. Plasma glucose levels of normal rats fed with cocoa extract (CE) 
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Values with different superscripts were statistically significant at the level of p < 0.05. 
DC: Diabetes control (n =6); DCE1: Diabetes + 1% CE (n = 4); DCE2: Diabetes + 2% 
CE (n = 5); DCE3: Diabetes + 3% CE (n = 5); DG: Diabetes + glibenclamide (n = 4). 
 
FIG. 2. Plasma glucose levels of diabetic rats fed with cocoa extract (CE) 
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The extract was prepared at the concentration of 0.05 to 2.0 mg/ml. Values are 
expressed as means ± S.E.M. of four replicate determinations. Values with different 
superscripts were statistically significant at the level of p < 0.05. 
 
FIG. 3. The effect of cocoa extract (CE) on in-vitro insulin secretion from BRIN-BD11 
cell lines 
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